BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 19293549)

  • 21. Chronic active Epstein-Barr virus infection with cutaneous and sinus lymphoproliferation in a white female patient with 25 years' follow-up: an original case report.
    Picard C; Gouarin S; Comoz F; Barreau M; Verneuil L; Troussard X; Dompmartin A
    Br J Dermatol; 2015 Nov; 173(5):1266-70. PubMed ID: 26148205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma.
    Cho J; Kim SJ; Park S; Yoo KH; Ki CS; Ko Y; Kim WS
    Ann Hematol; 2018 Aug; 97(8):1427-1436. PubMed ID: 29627879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on expression of natural killer (NK) cell C-type lectin-like receptors in nasal NK/T-cell lymphomas].
    Nong L; Zhang S; Li Y; Zhang Y; Wang Y; Li T
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):319-24. PubMed ID: 20654155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
    Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
    Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case report: Immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics.
    Wang Y; Zhang M; Xue Q; Zhou H; Chen J; Wang H; Zhang Y; Shi W
    Front Immunol; 2023; 14():1172307. PubMed ID: 37138889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic mutations in
    Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP
    Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.
    Lin N; Ku W; Song Y; Zhu J; Lu Z
    Oncologist; 2019 Sep; 24(9):e905-e913. PubMed ID: 30940744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The superiority of Epstein-Barr virus DNA in plasma over in peripheral blood mononuclear cells for monitoring EBV-positive NK-cell lymphoproliferative diseases.
    Zheng M; Bao Y; Wang J; Ma Y; Yang Y; Zhang P; Chen L; Zheng K; Zhou J
    Hematol Oncol; 2022 Aug; 40(3):381-389. PubMed ID: 35405763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
    Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
    Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
    Tajima S; Takanashi Y; Koda K; Fukayama M
    Pathol Int; 2015 Dec; 65(12):661-5. PubMed ID: 26459854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.
    Qin C; Huang Y; Feng Y; Li M; Guo N; Rao H
    Diagn Pathol; 2018 Feb; 13(1):17. PubMed ID: 29482573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting.
    Cohen JI; Iwatsuki K; Ko YH; Kimura H; Manoli I; Ohshima K; Pittaluga S; Quintanilla-Martinez L; Jaffe ES
    Leuk Lymphoma; 2020 Apr; 61(4):808-819. PubMed ID: 31833428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma.
    Kim HS; Kim KH; Kim KH; Chang MH; Ji SH; Lim DH; Kim K; Kim SJ; Ko Y; Ki CS; Jo SJ; Lee JW; Kim WS
    Leuk Lymphoma; 2009 May; 50(5):757-63. PubMed ID: 19330658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EBV in T-/NK-Cell Tumorigenesis.
    Kimura H
    Adv Exp Med Biol; 2018; 1045():459-475. PubMed ID: 29896680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired hemophilia A associated with Epstein-Barr-virus-associated T/natural killer-cell lymphoproliferative disease: A case report.
    Yamamoto M; Shindo M; Sumi C; Igarashi S; Saito T; Tsukada N; Toki Y; Hatayama M; Inamura J; Sato K; Mizukami Y; Torimoto Y; Okumura T
    Medicine (Baltimore); 2021 Apr; 100(16):e25518. PubMed ID: 33879690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Series of extranodal natural killer/T-cell lymphoma, nasal type, with periorbital involvement.
    Termote K; Dierickx D; Verhoef G; Jorissen M; Tousseyn T; Mombaerts I
    Orbit; 2014 Aug; 33(4):245-51. PubMed ID: 24831171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic active Epstein-Barr virus infection: A heterogeneous entity requiring a high index of suspicion for diagnosis.
    Ondrejka SL; Hsi ED
    Int J Lab Hematol; 2020 Jun; 42 Suppl 1():99-106. PubMed ID: 32543060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective Epstein-Barr virus in chronic active infection and haematological malignancy.
    Okuno Y; Murata T; Sato Y; Muramatsu H; Ito Y; Watanabe T; Okuno T; Murakami N; Yoshida K; Sawada A; Inoue M; Kawa K; Seto M; Ohshima K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Narita Y; Yoshida M; Goshima F; Kawada JI; Nishida T; Kiyoi H; Kato S; Nakamura S; Morishima S; Yoshikawa T; Fujiwara S; Shimizu N; Isobe Y; Noguchi M; Kikuta A; Iwatsuki K; Takahashi Y; Kojima S; Ogawa S; Kimura H
    Nat Microbiol; 2019 Mar; 4(3):404-413. PubMed ID: 30664667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric oral Epstein-Barr virus associated self-remitting CD30+ lymphoproliferative disorder: A distinct entity.
    Schwartz Z; Bowe RB; Coleman M; Magro CM
    Ann Diagn Pathol; 2018 Dec; 37():57-61. PubMed ID: 30292067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.